{"title":"Playing Telephone: How Secondary Messengers Influence Host-Pathogen Interactions in Tuberculosis.","authors":"Srivathsa Shankar Kurpad, Neeraj Dhar","doi":"10.1021/acsinfecdis.5c00077","DOIUrl":null,"url":null,"abstract":"<p><p>Secondary messengers are small, diffusible signaling molecules that transmit information from environmental cues detected at the cell surface by extracellular signaling molecules (primary messengers) to effector proteins, thereby enabling an appropriate cellular response. These molecules include cyclic nucleotides, alarmones, and lipid-derived metabolites and are ubiquitous regulators, influencing processes such as growth, metabolism, and neurotransmission in mammalian cells, as well as chemotaxis, biofilm formation, and metabolism in prokaryotes. <i>Mycobacterium tuberculosis</i> encodes an extensive array of genes dedicated to the synthesis and degradation of a diverse range of secondary messenger molecules. Given its highly intricate intracellular lifestyle and its ability to endure and persist in hostile and fluctuating environments, there is significant potential for crosstalk between host and bacterial secondary messengers. <i>M. tuberculosis</i> has likely co-opted these signaling processes within the host cell to facilitate its own pathogenesis and virulence. Recent studies have begun to elucidate the complex and multifaceted roles played by some of these secondary messengers, highlighting their capacity to regulate mycobacterial physiology while simultaneously modulating host immune responses. This review summarizes the current understanding of secondary messenger signaling in <i>M. tuberculosis</i> and explores how this knowledge is being leveraged to develop improved vaccines and therapeutic strategies.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":4.0000,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acsinfecdis.5c00077","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Secondary messengers are small, diffusible signaling molecules that transmit information from environmental cues detected at the cell surface by extracellular signaling molecules (primary messengers) to effector proteins, thereby enabling an appropriate cellular response. These molecules include cyclic nucleotides, alarmones, and lipid-derived metabolites and are ubiquitous regulators, influencing processes such as growth, metabolism, and neurotransmission in mammalian cells, as well as chemotaxis, biofilm formation, and metabolism in prokaryotes. Mycobacterium tuberculosis encodes an extensive array of genes dedicated to the synthesis and degradation of a diverse range of secondary messenger molecules. Given its highly intricate intracellular lifestyle and its ability to endure and persist in hostile and fluctuating environments, there is significant potential for crosstalk between host and bacterial secondary messengers. M. tuberculosis has likely co-opted these signaling processes within the host cell to facilitate its own pathogenesis and virulence. Recent studies have begun to elucidate the complex and multifaceted roles played by some of these secondary messengers, highlighting their capacity to regulate mycobacterial physiology while simultaneously modulating host immune responses. This review summarizes the current understanding of secondary messenger signaling in M. tuberculosis and explores how this knowledge is being leveraged to develop improved vaccines and therapeutic strategies.
期刊介绍:
ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to:
* Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials.
* Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets.
* Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance.
* Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents.
* Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota.
* Small molecule vaccine adjuvants for infectious disease.
* Viral and bacterial biochemistry and molecular biology.